Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2388]

FDA grants accelerated approval to pembrolizumab for HER2-positive gastric cancer

FDA grants accelerated approval to pembrolizumab for HER2-positive gastric cancer

Using personalised medicine to avoid resistance to leukaemia treatment

Using personalised medicine to avoid resistance to leukaemia treatment

Personalised follow-up care needed to address varying health burdens in breast cancer patients

Personalised follow-up care needed to address varying health burdens in breast cancer patients

Panel finds 30-day course of VTE prophylaxis post-discharge improves outcomes

Panel finds 30-day course of VTE prophylaxis post-discharge improves outcomes

For young breast cancer patients, fertility concerns influence therapy decisions

For young breast cancer patients, fertility concerns influence therapy decisions

NUS researchers discover protein that promotes chemotherapy resistance

NUS researchers discover protein that promotes chemotherapy resistance

Side effect of cancer treatment can be safely reduced with topical cream

Side effect of cancer treatment can be safely reduced with topical cream

Genetic changes in head and neck cancer, immunotherapy resistance identified

Genetic changes in head and neck cancer, immunotherapy resistance identified

Age-related muscle loss and walking abilities predict outcomes after lung cancer surgery

Age-related muscle loss and walking abilities predict outcomes after lung cancer surgery

FDA grants accelerated approval to dostarlimab-gxly for dMMR endometrial cancer

FDA grants accelerated approval to dostarlimab-gxly for dMMR endometrial cancer

More from ecancer